Carcinoid syndrome laboratory tests: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Carcinoid syndrome}} {{CMG}} ==Overview== ==References== {{reflist|2}} Category:Disease Category:Types of cancer Category:Hematology Category:Oncology [[...")
 
No edit summary
Line 3: Line 3:


==Overview==
==Overview==
With a certain degree of clinical suspicion, [[diagnosis]] is made primarily by measuring plasma levels of the secreted glycoprotein Chromogranin A, supported by measuring the 24 hour [[urine]] levels of [[5-HIAA]] (5-hydroxyindoleacetic acid), a breakdown product of serotonin.  Patients with carcinoid syndrome usually excrete >25 mg of 5-HIAA per day.


==References==
==References==

Revision as of 19:37, 6 August 2012

Carcinoid syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carcinoid Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carcinoid syndrome laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carcinoid syndrome laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carcinoid syndrome laboratory tests

CDC on Carcinoid syndrome laboratory tests

Carcinoid syndrome laboratory tests in the news

Blogs on Carcinoid syndrome laboratory tests

Directions to Hospitals Treating Carcinoid syndrome

Risk calculators and risk factors for Carcinoid syndrome laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

With a certain degree of clinical suspicion, diagnosis is made primarily by measuring plasma levels of the secreted glycoprotein Chromogranin A, supported by measuring the 24 hour urine levels of 5-HIAA (5-hydroxyindoleacetic acid), a breakdown product of serotonin. Patients with carcinoid syndrome usually excrete >25 mg of 5-HIAA per day.

References


Template:WikiDoc Sources